Download PDF
Thromb Haemost 1975; 33(02): 199-207
DOI: 10.1055/s-0038-1647872
Original Article
Schattauer GmbH

Data for Defining Fibrinogen and Its Plasmic Degradation Products

Victor J Marder
1   Department of Medicine and the Specialized Center of Research in Thrombosis, Temple University Health Sciences Center, Philadelphia, Pennsylvania 19140
,
Andrei Z Budzynski
1   Department of Medicine and the Specialized Center of Research in Thrombosis, Temple University Health Sciences Center, Philadelphia, Pennsylvania 19140
› Author Affiliations
Further Information

Publication History

Received 30 December 1974

Accepted 07 January 1975

Publication Date:
02 July 2018 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Alkjaersig N, Fletcher A. P, Sherry S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic (“fibrinolytic”) states II. The significance, mechanism and consequences of defective fibrin polymerization.. Journal of Clinical Investigation 1962; 41: 917
    CrossrefPubMedGoogle Scholar
  • 2 Blombäck B, Vestermark A. Studies on fibrinopeptides. Arkiv Kemi 1958; 12: 173
    PubMedGoogle Scholar
  • 3 Blombäck B, Blombäck M, Edman P, Hessel B. Human fibrinopeptides Isolation, characterization and structure. Biochimica et Biophysica Acta 1966; 115: 371
    CrossrefPubMedGoogle Scholar
  • 4 Blombäck B, Blombäck M, Henschen A, Hessel B, Iwanaga S, Woods K. R. N-terminal disulfide knot of human fibrinogen. Nature 1968; 218: 130
    CrossrefPubMedGoogle Scholar
  • 5 Blombäck B. Selectional trends in the structure of fibrinogen of different species. Symposium of the Zoological Society of London 1910; 27: 167
    PubMedGoogle Scholar
  • 6 Blombäck B, Johnson A. J. Joint report of the subcommittees of nomenclature and on fibrinolysis, thrombolysis and intravascular coagulation. Thrombosis et Diathesis Haemorrhagica Suppl. 51 1971; 251
    PubMedGoogle Scholar
  • 7 Blombäck B. Report of the subcommittee on nomenclature. Thrombosis et Diathesis Haemorrhagica Suppl. 54 1973; 425
    PubMedGoogle Scholar
  • 8 Budzynski A. Z. Structure of fibrinogen in relation to its proteolytic degradation products. Postępy Higieny in Medycyny Dóswiadczalnej 1969; 23: 293
    PubMedGoogle Scholar
  • 9 Budzynski A. Z, Stahl M, Kopeć M, Latallo Z. S, Wegrzynowicz Z, Kowalski E. High molecular weight products of the late stage of fibrinogen proteolysis by plasmin and their structural relation to the fibrinogen molecule. Biochimica et Biophysica Acta 147 1967; 313
    CrossrefPubMedGoogle Scholar
  • 10 Budzynski A. Z, Marder V. J, Shainoff J. R. Structure of plasmic degradation products of human fibrinogen. Fibrinopeptide and polypeptide chain analysis. Journal of Biological Chemistry 1974; 249: 2294
    PubMedGoogle Scholar
  • 11 Caspary E. A, Kekwick R. A. Some physicochemical properties of human fibrinogen. Biochemical Journal 1957; 67: 41
    CrossrefPubMedGoogle Scholar
  • 12 Chen R, Doolittle R. F. γ-γ cross-linking sites in human and bovine fibrin. Biochemistry 10 1971; 4486
    CrossrefPubMedGoogle Scholar
  • 13 Collen et al. 1975
    PubMed
  • 14 Donnelly T. H, Laskowski jr. M, Notley N, Scheraga H. A. Equilibria in the fibrinogen — fibrin conversion II. Reversibility of the polymerization steps. Archives of Biochemistry and Biophysics 1956; 56: 369
    PubMedGoogle Scholar
  • 15 Dudek G. A, Kloczewiak M, Budzynski A. Z, Latallo Z. S, Kopeć M. Characterization and comparison of macromolecular end products of fibrinogen and fibrin proteolysis by plasmin. Biochimica et Biophysica Acta 1970; 214: 44
    CrossrefPubMedGoogle Scholar
  • 16 Endres G. F, Scheraga H. A. Molecular weight of bovine fibrinogen by sedimentation equilibrium. Archives of Biochemistry and Biophysics 1971; 144: 519
    CrossrefPubMedGoogle Scholar
  • 17 Fletcher A. P, Alkjaersig N, Fisher S, Sherry S. The proteolysis of fibrinogen by plasmin: the identification of thrombinclottable fibrinogen derivatives which polymerize abnormally. Journal of Laboratory and Clinical Medicine 1966; 68: 780
    PubMedGoogle Scholar
  • 18 Furlan M, Beck E. A. Plasmic degradation of human fibrinogen I. Structural characterization of degradation products. Biochimica et Biophysica Acta 263 1972; 631
    CrossrefPubMedGoogle Scholar
  • 19 Furlan M, Beck E. A. Plasmic degradation of human fibrinogen II. Further characterization of Fragment D. Biochimica et Biophysica Acta 310 1973; 205
    CrossrefPubMedGoogle Scholar
  • 20 Furlan M, Kemp G, Beck E. A. The covalent structure of Fragment D from human fibrinogen. Biochimica et Biophysica Acta, in press 1975
    PubMedGoogle Scholar
  • 21 Gaffney P. J, Brasher M. Subunit structure of the plasmininduced degradation products of crosslinked fibrin. Biochimica et Biophysica Acta 295 1973; 308
    CrossrefPubMedGoogle Scholar
  • 22 Gaffney P. J, Dobos P. A structural aspect of human fibrinogen suggested by its plasmin degradation. FEBS letters 1971; 15: 13
    CrossrefPubMedGoogle Scholar
  • 23 GÅrdlund B, Kowalska-Loth B, Gröndahl N. J, Blombäck B. Plasmic degradation products of human fibrinogen I. Isolation and characterization of Fragments E and D and their relation to “Disulfide knots.”. Thrombosis Research 1972; 1: 371
    CrossrefPubMedGoogle Scholar
  • 24 Gladner J. A, Folk J. E, Laki K, Carroll W. R. Thrombin-induced formation of co-fibrin I. Isolation, purification, and characterization of co-fibrin.. Journal of Biological Chemistry 1959; 234: 62
    PubMedGoogle Scholar
  • 25 Kierulf P. N-terminal analysis of “fibrins” from plasmin hydrolysed fibrinogenevidence for lack of fibrinopeptide B. Thrombosis Research 1972; 1: 527
    CrossrefPubMedGoogle Scholar
  • 26 Kopeć M, Teisseyre E, Dudek-Wojciechowska G, Kloczewiak M, Pankiewicz A, Latallo Z. S. Studies on the “Double D” fragment from stabilized bovine fibrin. Thrombosis Research 1973; 2: 283
    CrossrefPubMedGoogle Scholar
  • 27 Kowalska-Loth B, GÅrdlund B, Egberg N, Blombäck B. Plasmic degradation products of human fibrinogen I. Chemical and immunological relation between Fragment E and N-DSK.. Thrombosis Research 1973; 2: 423
    CrossrefPubMedGoogle Scholar
  • 28 Larrieu M. J, Marder V. J, Inceman S. Effects of fibrinogen degradation products on platelets and coagulation. In: Diffuse Intravascular Clotting. Transaction of the International Committee on Haemostasis and Thrombosis 1965 Stuttgart, F. K.; Schattauer-Verlag: 1966: 215
    Google Scholar
  • 29 Larrieu M. J, Rigollot C, Marder V. J. Comparative effects of fibriogen degradation Fragments D and E on coagulation. British Journal of Haematology 1972; 22: 719
    CrossrefPubMedGoogle Scholar
  • 30 Latallo Z. S, Fletcher A. P, Alkjaersig N, Sherry S. Inhibition of fibrin polymerization by fibrinogen proteolysis products. American Journal of Physiology 1962; 202: 681
    PubMedGoogle Scholar
  • 31 Latallo Z. S, Budzynski A. Z, Lipinski B, Kowalski E. Inhibition of thrombin and of fibrin polymerization. Two activities derived from plasmindigested fibrinogen. Nature 1964; 203: 1184
    CrossrefPubMedGoogle Scholar
  • 32 Marder V. J, Shulman N. R, Carroll W. R. The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage. Transactions of the Association of American Physicians 1967; 53: 156
    PubMedGoogle Scholar
  • 33 Marder V. J, Shulman N. R, Carroll W. R. High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization. Journal of Biological Chemistry 1969; a 244: 2111
    PubMedGoogle Scholar
  • 34 Marder V. J, Shulman N. R. High molecular weight derivatives of human fibrinogen produced by plasmin. II. Mechanism of their anticoagulant activity. Journal of Biological Chemistry 1969; b 244: 2120
    PubMedGoogle Scholar
  • 35 Marder V. J, Budzynski A. Z. Classification of fibrinogen derivatives. Thrombosis et Diathesis Haemorrhagica supplement 1971; a 51: 267
    PubMedGoogle Scholar
  • 36 Marder V. J. Fibrinogen and fibrin degradation products. Physicochemical and physiological considerations. Thrombosis et Diathesis Haemorrhagica Suppl. 85 47 1971; b
    PubMedGoogle Scholar
  • 37 Marder V. J. Identification and purification of fibrinogen degradation products produced by plasmin. Considerations on the structure of fibrinogen In: Verstraete M, Vermylen J, Donati M. B. (Eds.) Fibrinogen Degradation Products. International Workshop, Leuven, Belgium. Scandinavica Haematologica supplement 1971; 13: 21
    PubMedGoogle Scholar
  • 38 Marder V. J, Budzynski A. Z, James H. L. High molecular weight derivatives of human fibrinogen produced by plasmin III. Their NH2-terminal amino acids and comparison with the “NH2-terminal disulfide knot.”. Journal of Biological Chemistry 1972; 247: 4775
    PubMedGoogle Scholar
  • 39 Marguerie 1975
    PubMed
  • 40 Mills D, Karpatkin S. Heterogeneity of human fibrinogen: Possible relation to proteolysis by thrombin and plasmin as studied by SDS-Polyacrylamide gel electrophoresis. Biochemical and Biophysical Research Communication 1970; 40: 206
    CrossrefPubMedGoogle Scholar
  • 41 Mills D, Karpatkin S. The initial macromolecular derivatives of human fibrinogen produced by plasmin. Biochimica Biophysica Acta 1972; 271: 163
    CrossrefPubMedGoogle Scholar
  • 42 Mills D. A. Molecular mode for the proteolysis of human fibrinogen by plasmin. Biochimica et Biophysica Acta 1972; 263: 619
    CrossrefPubMedGoogle Scholar
  • 43 Mosesson M. W, Alkjaersig N, Sweet B, Sherry S. Human fibrinogen of relatively high solubility. Comparative biophysical, biochemical, and biological studies with fibrinogen of lower solubility. Biochemistry 1967; 6: 3279
    CrossrefPubMedGoogle Scholar
  • 44 Mosesson M. W, Umfleet R. A. The cold-insoluble globulin of human plasma. I. Purification, primary characterization, and relationship to fibrinogen and other cold-insoluble fraction components. Journal of Biological Chemistry 1970; 245: 5728
    PubMedGoogle Scholar
  • 45 Mosesson M. W, Finlayson J. S, Umfleet R. A. Human Fibrinogen Heterogeneities. III. Identification of γ-chain variants.. Journal of Biological Chemistry 1972; 247: 5223
    PubMedGoogle Scholar
  • 46 Mosesson M. W, Finlayson J. S, Galankis D. K. The essential covalent structure of human fibrinogen envinced by analysis of derivatives formed during plasmic hydrolysis. Journal of Biological Chemistry 1973; 249: 7913
    PubMedGoogle Scholar
  • 47 McKee P. A, Rogers L. A, Marler E, Hill R. L. The subunit polypeptides of human fibrinogen. Archives of Biochemistry and Biophysics 1966; 116: 271
    CrossrefPubMedGoogle Scholar
  • 48 Niléhn J. E. Split products of fibrinogen after prolonged interaction with plasmin. Thrombosis et Diathesis Haemorrhagica 1967; 18: 89
    PubMedGoogle Scholar
  • 49 Nussenzweig V, Seligmann M, Pelmont U, Grabar P. Les produits de dégradation du fibrinogène humain par la plasmine. I. Séparation et propriétés physico-chimiques.. Ann. Inst. Pasteur 1961; a 100: 377
    PubMedGoogle Scholar
  • 50 Nussenzweig V, Seligmann M, Grabar P. Les produits de dégradation du fibrinogène humain par la plasmine. II. Etude immunologique : Mise en évidence d’anticorps antifibrinogène natif possédant des spécificites différentes. Ann. Inst. Pasteur 1961; b 100: 490
    PubMedGoogle Scholar
  • 51 Okude M, Iwanaga S. Carboxy-terminal residues of mammalian fibrinogen and fibrin. Biochimica et Biophysica Acta 1971; 251: 185
    CrossrefPubMedGoogle Scholar
  • 52 Pizzo S. V, Schwartz M. L, Hill R. L, McKee P. A. The effect of plasmin on the subunit structure of human fibrinogen. Journal of Biological Chemistry 1972; 247: 636
    PubMedGoogle Scholar
  • 53 Pizzo S. V, Schwartz M. L, Hill R. L, McKee P. A. The effect of plasmin on the subunit structure of human fibrin. Journal of Biological Chemistry 1973; a 248: 4574
    PubMedGoogle Scholar
  • 54 Pizzo S. V, Taylor Jr. L. M, Schwartz M. L, Hill R. L, McKee P. A. Subunit structure of fragment D from fibrinogen and cross-linked fibrin. Journal of Biological Chemistry 248 1973; b 4584
    PubMedGoogle Scholar
  • 55 Shulman S. The size and shape of bovine fibrinogen. Studies of sedimentation diffusion and viscosity. Journal of the American Chemistry Society 1953; 75: 5846
    CrossrefPubMedGoogle Scholar
  • 56 Triantaphyllopoulos D. C, Triantaphyllopoulos E. Evidence of antithrombotic activity of the anticoagulant fraction of incubated fibrinogen. British Journal of Haematology 1966; 12: 145
    CrossrefPubMedGoogle Scholar